New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
11:14 EDTARUN, CHTP, ISIS, QLIK, PRANOptions with decreasing implied volatility: CHTP PRAN ISIS ARUN QLIK
News For CHTP;PRAN;ISIS;ARUN;QLIK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 20, 2014
14:44 EDTARUNAruba Networks volatility elevated into Q1 an outlook
Subscribe for More Information
09:44 EDTARUNAruba Networks Q1 EPS should beat consensus, says Janney Capital
Janney Capital said its reseller checks show good demand for 802.11ac products and the firm believes Aruba Networks should deliver Q1 earnings that top consensus. However, the firm continues to expect Aruba's competition will intensify in early 2015 and maintains its $24 fair value estimate and Neutral rating on the stock.
07:24 EDTISISGoldman to hold a conference
Subscribe for More Information
06:40 EDTISISIsis Pharmaceuticals price target raised to $62 from $53 at Piper Jaffray
Subscribe for More Information
November 19, 2014
08:31 EDTQLIKQlik Technologies price target raised to $36 from $32 at JMP Securities
JMP Securities increased its price target on Qlik after attending the company's user conference. The firm notes that the company feels confident it can accelerate its revenue growth next year while also expanding its operating margins. JMP Securities remains upbeat on Qlik's outlook and believes it is executing well. The firm keeps an Outperform rating on the shares.
08:07 EDTQLIKQlik Technologies growth poised to accelerate in 2015, says Pacific Crest
Subscribe for More Information
November 18, 2014
15:48 EDTISISGenzyme, Isis present KYNAMRO data at AHA meeting
Genzyme, a Sanofi (SNY) company, and Isis Pharmaceuticals (ISIS) announced that new two-year data from a phase 3 long-term extension study of KYNAMRO injection was presented at a scientific session at the annual American Heart Association meeting. In the study, a retrospective analysis showed that patients treated with KYNAMRO for a mean of two years had a significant reduction in Major Adverse Cardiovascular Events compared to two years prior to therapy. The rate of MACE in patients treated with KYNAMRO for two years were adjudicated by an independent committee and compared to the rate of MACE in the same patients based on their medical history prior to treatment with KYNAMRO. In this analysis, MACE were identified in 62% of patients during two years prior to KYNAMRO treatment, and 9% of patients during a mean of 24.4 months after initiation of treatment with KYNAMRO.
07:45 EDTQLIKQlik Technologies to hold a presentation at conference
At the Qlik World Conference 2014, management holds a webcasted financial analyst presentation on November 18 at 3:15 pm. Webcast Link
November 17, 2014
11:28 EDTARUNAruba Networks Q1 sales likely ahead of expectations, says Piper Jaffray
Subscribe for More Information
07:49 EDTARUNAruba Networks estimates appear achievable, says UBS
UBS remains a buyer of Aruba Networks ahead of its Q1 results, as the firm sees improving operational discipline and cost cutting, continuation of its product cycle, free cash flow, and new partnerships. UBS reiterated its Buy rating and $25 price target on Aruba Networks shares.
07:19 EDTQLIKQlik Technologies to hold a conference
Subscribe for More Information
November 14, 2014
15:41 EDTISISIsis Pharmaceuticals management to meet with Piper Jaffray
Meeting to be held in Kansas City, MO on November 18 hosted by Piper Jaffray.
November 13, 2014
09:40 EDTARUNActive equity options trading
Subscribe for More Information
05:34 EDTISISAstraZeneca, Isis Pharmaceuticals to co-develop oligonucleotide delivery methods
Subscribe for More Information
November 12, 2014
08:37 EDTARUNAruba Networks shares should be bought into earnings, says Pacific Crest
Subscribe for More Information
07:53 EDTISISLeerink to hold a tour
Subscribe for More Information
November 11, 2014
10:00 EDTQLIKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:20 EDTQLIKQlik Technologies initiated with an Outperform at Macquarie
Subscribe for More Information
November 10, 2014
16:07 EDTISISIsis Pharmaceuticals files to sell $425M in convertible senior notes due 2021
Subscribe for More Information
08:06 EDTQLIKQlik Technologies, Intuit partner to deliver accounting analytics solutions
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use